| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Canada | 2 | |
| #5 | Australia | 1 | |
| #6 | Israel | 1 | |
| #7 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Analysing materials | |
| #3 | Medical preparations | |
| #4 | Therapeutic chemical compounds | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Holtzman Jordan L | 13 |
| Publication | Filing date | Title |
|---|---|---|
| WO2014012108A1 | Cellular and animal models for screening therapeutic agents for the treatment of alzheimer's disease | |
| WO2009021113A1 | Methods for enhancing glutahione peroxidase activity | |
| EP1289512A2 | Agents and methods for increasing brain chaperonin levels | |
| EP1125135A2 | A complex of a chaperone with beta-amyloid and methods employing this complex |